Magnesium toxicity from OTC drugs "underestimated," FDAers say in journal article.
This article was originally published in The Tan Sheet
Executive Summary
MAGNESIUM TOXICITY FROM OTC DRUGS "UNDERESTIMATED" by consumers and health care professionals, according to an article by three FDAers in the August issue of the American Medical Association's Archives of Family Medicine. The study, based on adverse event reports collected in FDA's MEDWATCH database, a case report and a literature review, was authored by former OTC Medical Officer Man Fung, MD, Office of OTC Drug Evaluation Director Michael Weintraub, MD, and Medical Review Staff Director Debra Bowen, MD.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning